Small molecule inhibitors of herpes simplex virus type 1 immediate early gene expression

Drug News and Perspectives

Volumn 15, Issue 5, 2002, Pages 299-305

  Weber, Peter C ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 FLUOROHEXACARBONYL) 1,4 DIHYDRO 4 OXO 7 (4 PYRIDINYL) 3 QUINOLINECARBOXAMIDE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; NUCLEOSIDE ANALOG; PD 146626; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN ICP0; PROTEIN VP16; QC 17; ROSCOVITINE; SCH 49286; TETRA O METHYL NORDIHYDROGUAIARETIC ACID; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; CELL VIABILITY; CYTOTOXICITY; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMEDIATE EARLY GENE; LATENT VIRUS INFECTION; PROTEIN INTERACTION; REVIEW; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0036071755     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2002.15.5.704683     Document Type: Review

References (31)

1. Acyclovir-resistant, pathogenic herpesviruses
2. "The end of innocence" revisited: Resistance of herpesviruses to antiviral drugs
3. Repression of viral transcription during herpes simplex virus latency
4. A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice
5. Immediate early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency
6. ICPO, a regulator of herpes simplex virus during lytic and latent infection
7. Viral transactivating proteins
8. Regulation of DNA virus transcription by cellular POU family transcription factors
9. A surprising role for the proteasome in the regulation of hervesvirus infection
10. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms
11. Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110
12. Herpes simplex virus type 1 immediate-early protein ICP0 and its isolated RING finger domain act as ubiquitin E3 ligases in vitro
13. A viral activator of gene expression functions via the ubiquitin-proteasome pathway
14. Cyclin-dependent kinases: Engines, clocks, and microprocessors
15. ATP-site directed inhibitors of cyclin-dependent kinases
16. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription
17. Transactivation of herpes simplex virus type 1 immediate-early gene expression by virion-associated factors is blocked by an inhibitor of cyclin-dependent protein kinases
18. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases
19. Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins
20. A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function
21. A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for 1CP0, a transactivating protein of herpes simplex virus type 1
22. Herpes simplex virus 1 alpha regulatory protein 1CP0 interacts with and stabilizes the cell cycle regulator cyclin D3
23. Nuclear dots: Actors on many stages
24. Cell cycle regulation of PML modification and ND10 composition
25. Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate-early' gene transcription in vitro
26. Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification, and inhibition of Tat-regulated HIV transactivation
27. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA
28. SCH 43478 and analogs: In vitro activity and in vivo efficacy of novel agents for herpesvirus type 2
29. Antiviral properties of 3-quinolinecarbox-amides: A series of novel non-nucleoside antiherpetic agents
30. Identification and characterization of a benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection